{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T06:02:30Z","timestamp":1781244150869,"version":"3.54.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lungcancerjournal.info","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.lungcan.2018.07.007","type":"journal-article","created":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T14:49:16Z","timestamp":1530802156000},"page":"12-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Current efforts in research of pleural mesothelioma\u2014An analysis of the ClinicalTrials.gov registry"],"prefix":"10.1016","volume":"124","author":[{"given":"Krisztian","family":"S\u00fcveg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul Martin","family":"Putora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Berghmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Glatzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veljko","family":"Kovac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1534-8520","authenticated-orcid":false,"given":"Nikola","family":"Cihoric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.lungcan.2018.07.007_bib0005","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2018.07.007_bib0010","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5223(99)70469-1","article-title":"Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients","volume":"117","author":"Sugarbaker","year":"1999","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"1","key":"10.1016\/j.lungcan.2018.07.007_bib0015","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.lungcan.2009.08.019","article-title":"Survival after trimodality therapy for malignant pleural mesothelioma: radical pleurectomy, chemotherapy with cisplatin\/pemetrexed and radiotherapy","volume":"71","author":"B\u00f6l\u00fckbas","year":"2011","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2018.07.007_bib0020","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s13014-015-0575-5","article-title":"Long-term results in malignant pleural mesothelioma treated with neoadjuvant chemotherapy, extrapleural pneumonectomy and intensity-modulated radiotherapy","volume":"10","author":"Thieke","year":"2015","journal-title":"Radiat. Oncol."},{"issue":"18","key":"10.1016\/j.lungcan.2018.07.007_bib0025","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1200\/JCO.2008.20.3943","article-title":"Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma","volume":"27","author":"Krug","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.lungcan.2018.07.007_bib0030","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/annonc\/mdm093","article-title":"Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma","volume":"18","author":"Weder","year":"2007","journal-title":"Ann. Oncol."},{"issue":"9","key":"10.1016\/j.lungcan.2018.07.007_bib0035","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1200\/JCO.2008.17.5604","article-title":"Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma","volume":"27","author":"de Perrot","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2018.07.007_bib0040","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1200\/JCO.1998.16.1.145","article-title":"Prognostic factors in patients with pleural mesothelioma: the European organization for research and treatment of cancer experience","volume":"16","author":"Curran","year":"1998","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.lungcan.2018.07.007_bib0045","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1378\/chest.113.3.723","article-title":"Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the cancer and leukemia group B","volume":"113","author":"Herndon","year":"1998","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.lungcan.2018.07.007_bib0050","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1097\/JTO.0b013e3182208e3f","volume":"6","author":"Rice","year":"2011","journal-title":"J. Thorac. Oncol."},{"issue":"4","key":"10.1016\/j.lungcan.2018.07.007_bib0055","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1067\/mtc.2001.116560","article-title":"A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma","volume":"122","author":"Rusch","year":"2001","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"10026","key":"10.1016\/j.lungcan.2018.07.007_bib0060","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(15)01238-6","article-title":"Bevacizumab for newly diagnosed pleural mesothelioma in the mesothelioma avastin cisplatin pemetrexed study (MAPS): a randomised, controlled, open-label, phase 3 trial","volume":"387","author":"Zalcman","year":"2016","journal-title":"Lancet"},{"issue":"01","key":"10.1016\/j.lungcan.2018.07.007_bib0065","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1055\/s-2007-1013677","article-title":"Videothoracoscopy in the diagnosis and treatment of malignant pleural mesothelioma with associated pleural effusions","volume":"45","author":"Canto","year":"1997","journal-title":"Thorac. Cardiovasc. Surg."},{"issue":"9948","key":"10.1016\/j.lungcan.2018.07.007_bib0070","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S0140-6736(14)60418-9","article-title":"Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial","volume":"384","author":"Rintoul","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.lungcan.2018.07.007_bib0075","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.76.6394","article-title":"Treatment of malignant pleural mesothelioma: American society of clinical oncology clinical practice guideline","author":"Kindler","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"Suppl. 1","key":"10.1016\/j.lungcan.2018.07.007_bib0080","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thoraxjnl-2017-211321","article-title":"British thoracic society guideline for the investigation and management of malignant pleural mesothelioma","volume":"73","author":"Woolhouse","year":"2018","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.lungcan.2018.07.007_bib0085","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S1470-2045(17)30169-9","article-title":"Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial","volume":"18","author":"Alley","year":"2017","journal-title":"Lancet Oncol."},{"issue":"31","key":"10.1016\/j.lungcan.2018.07.007_bib0090","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1200\/JCO.2017.72.9012","article-title":"Nintedanib plus pemetrexed\/cisplatin in patients with malignant pleural mesothelioma: phase II results from the randomized, placebo-controlled LUME-meso trial","volume":"35","author":"Grosso","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2018.07.007_bib0095","article-title":"Phase I clinical trial of the chimeric anti-mesothelin monoclonal antibody MORAb-009 in patients with mesothelin expressing cancers","volume":"2275","author":"Hassan","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2018.07.007_bib0100","article-title":"Mesothelin-targeted immunotherapy CRS-207 in combination with standard of care chemotherapy as treatment for malignant pleural mesothelioma (MPM)","author":"Hassan","year":"2015","journal-title":"Multiple Journal Found"},{"issue":"2","key":"10.1016\/j.lungcan.2018.07.007_bib0105","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1158\/2326-6066.CIR-13-0170","article-title":"Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce antitumor activity in solid malignancies","volume":"2","author":"Beatty","year":"2014","journal-title":"Cancer Immunol. Res."},{"issue":"15","key":"10.1016\/j.lungcan.2018.07.007_bib0110","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1158\/1078-0432.CCR-15-2133","article-title":"Pilot and feasibility trial evaluating immuno-Gene therapy of malignant mesothelioma using intrapleural delivery of adenovirus-IFN\u03b1 combined with chemotherapy","volume":"22","author":"Sterman","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.lungcan.2018.07.007_bib0115","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1183\/09031936.00063109","article-title":"Guidelines of the European respiratory society and the European society of thoracic surgeons for the management of malignant pleural mesothelioma","volume":"35","author":"Scherpereel","year":"2010","journal-title":"Eur. Respir. J."},{"issue":"7","key":"10.1016\/j.lungcan.2018.07.007_bib0120","doi-asserted-by":"crossref","first-page":"477","DOI":"10.7326\/M13-0480","article-title":"Reporting discrepancies between the ClinicalTrials.Gov results database and peer-reviewed publications","volume":"160","author":"Hartung","year":"2014","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"10.1016\/j.lungcan.2018.07.007_bib0125","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3109\/02656736.2015.1040471","article-title":"Hyperthermia-related clinical trials on cancer treatment within the ClinicalTrials.gov registry","volume":"31","author":"Cihoric","year":"2015","journal-title":"Int. J. Hyperthermia"},{"issue":"1","key":"10.1016\/j.lungcan.2018.07.007_bib0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-016-0740-5","article-title":"Current status and perspectives of interventional clinical trials for glioblastoma\u2013analysis of ClinicalTrials. gov","volume":"12","author":"Cihoric","year":"2017","journal-title":"Radiat. Oncol."},{"issue":"6","key":"10.1016\/j.lungcan.2018.07.007_bib0135","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3109\/02656736.2015.1040471","article-title":"Hyperthermia-related clinical trials on cancer treatment within the ClinicalTrials. gov registry","volume":"31","author":"Cihoric","year":"2015","journal-title":"Int. J. Hyperthermia"},{"issue":"17","key":"10.1016\/j.lungcan.2018.07.007_bib0140","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1001\/jama.2012.3424","article-title":"Characteristics of clinical trials registered in ClinicalTrials. gov, 2007-2010","volume":"307","author":"Califf","year":"2012","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.lungcan.2018.07.007_bib0145","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13014-016-0624-8","article-title":"Portfolio of prospective clinical trials including brachytherapy: an analysis of the ClinicalTrials. gov database","volume":"11","author":"Cihoric","year":"2016","journal-title":"Radiat. Oncol."},{"issue":"11","key":"10.1016\/j.lungcan.2018.07.007_bib0150","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1001\/jamainternmed.2013.627","article-title":"Characteristics of oncology clinical trials: insights from a systematic analysis of ClinicalTrials.gov","volume":"173","author":"Hirsch","year":"2013","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.lungcan.2018.07.007_bib0155","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jhealeco.2016.01.012","article-title":"Innovation in the pharmaceutical industry: New estimates of R&D costs","volume":"47","author":"DiMasi","year":"2016","journal-title":"J. Health Econ."},{"issue":"8","key":"10.1016\/j.lungcan.2018.07.007_bib0160","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1470-2045(11)70149-8","article-title":"Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the mesothelioma and radical surgery (MARS) randomised feasibility study","volume":"12","author":"Treasure","year":"2011","journal-title":"Lancet Oncol."},{"issue":"12","key":"10.1016\/j.lungcan.2018.07.007_bib0165","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S1470-2045(11)70307-2","article-title":"The MARS feasibility trial: conclusions not supported by data","volume":"12","author":"Weder","year":"2011","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.lungcan.2018.07.007_bib0170","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jtcvs.2007.10.054","article-title":"Extrapleural pneumonectomy versus pleurectomy\/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients","volume":"135","author":"Flores","year":"2008","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"11","key":"10.1016\/j.lungcan.2018.07.007_bib0175","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2017.06.25","article-title":"Malignant pleural mesothelioma: adjuvant therapy with radiation therapy","volume":"5","author":"Rosenzweig","year":"2017","journal-title":"Ann. Transl. Med."},{"issue":"16","key":"10.1016\/j.lungcan.2018.07.007_bib0180","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/S1470-2045(15)00208-9","article-title":"Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17\/04): a randomised, international, multicentre phase 2 trial","volume":"16","author":"Stahel","year":"2015","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.lungcan.2018.07.007_bib0185","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/JTO.0000000000000499","article-title":"Is radiotherapy useful for treating pain in mesothelioma?: A phase II trial","volume":"10","author":"MacLeod","year":"2015","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2018.07.007_bib0190","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.radonc.2007.05.022","article-title":"A randomised controlled trial of intervention site radiotherapy in malignant pleural mesothelioma","volume":"84","author":"O\u2019Rourke","year":"2007","journal-title":"Radiother. Oncol."},{"issue":"5","key":"10.1016\/j.lungcan.2018.07.007_bib0195","doi-asserted-by":"crossref","DOI":"10.1183\/09031936.00079407","article-title":"Drain site radiotherapy in malignant pleural mesothelioma: a wasted resource","volume":"30","author":"Muirhead","year":"2007","journal-title":"Eur. Respir. J."},{"issue":"8","key":"10.1016\/j.lungcan.2018.07.007_bib0200","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S1470-2045(16)30095-X","article-title":"Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial","volume":"17","author":"Clive","year":"2016","journal-title":"Lancet Oncol."},{"issue":"147","key":"10.1016\/j.lungcan.2018.07.007_bib0205","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0098-2017","article-title":"Drug repurposing in malignant pleural mesothelioma: a breath of fresh air?","volume":"27","author":"Boyer","year":"2018","journal-title":"Eur. Respir. Rev."},{"issue":"3","key":"10.1016\/j.lungcan.2018.07.007_bib0210","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1378\/chest.108.3.754","article-title":"Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma: a randomized trial of local radiotherapy","volume":"108","author":"Boutin","year":"1995","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.lungcan.2018.07.007_bib0215","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.bjc.6601957","article-title":"A randomised trial of single-dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma","volume":"91","author":"Bydder","year":"2004","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.lungcan.2018.07.007_bib0220","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.ijrobp.2011.09.027","article-title":"Pleur al intensity-modulated radiotherapy for malignant pleural mesothelioma","volume":"83","author":"Rosenzweig","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.lungcan.2018.07.007_bib0225","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jtcvs.2015.09.129","article-title":"Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma","volume":"151","author":"de Perrot","year":"2016","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"Suppl 2","key":"10.1016\/j.lungcan.2018.07.007_bib0230","first-page":"S238","article-title":"Management of malignant pleural mesothelioma\u2014the European experience","volume":"6","author":"Opitz","year":"2014","journal-title":"J. Thorac. Dis."},{"issue":"4","key":"10.1016\/j.lungcan.2018.07.007_bib0235","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMsr1601330","article-title":"Update on trial registration 11 years after the ICMJE policy was established","volume":"376","author":"Zarin","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"19","key":"10.1016\/j.lungcan.2018.07.007_bib0240","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1001\/jama.297.19.2112","article-title":"Issues in the registration of clinical trials","volume":"297","author":"Zarin","year":"2007","journal-title":"JAMA"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500218304653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500218304653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T19:44:53Z","timestamp":1537991093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500218304653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":48,"alternative-id":["S0169500218304653"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2018.07.007","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current efforts in research of pleural mesothelioma\u2014An analysis of the ClinicalTrials.gov registry","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2018.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}